UnitedHealth Group Inc (UNH) Stock AnalysisUNHStock AnalysisUnitedHealth Group Inc

UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

UnitedHealth Group Inc is currently a hold. The stock is priced at $392.95, with a forward P/E ratio of 20.24, which is relatively high compared to sector averages, indicating potential overvaluation risks. Despite a solid year-to-date change of +16.81% and a 1-year change of +27.25%, the recent downgrade by Erste Group highlights concerns about low revenue growth expectations for 2026 and 2027. Additionally, insider selling has surged by 2854.33%, signaling potential caution among insiders. The main risk is the high medical care ratio of 86.7%, which pressures profit margins.

22 analysts cover UNH: 22 rate it Buy, 0 Hold and 0 Sell. The average price target is 397.82.